Locoweed poisoning occurs when livestock consume swainsonine-containing Astragalus and Oxytropis species over several weeks. Although the clinical and histologic changes of poisoning have been described, the dose or duration of swainsonine ingestion that results in significant or irreversible damage is not known. The purpose of this research was to document the swainsonine doses that produce clinical intoxication and histologic lesions. Twenty-one mixed-breed wethers were dosed by gavage with ground Oxytropis sericea to obtain swainsonine doses of 0.0, 0.05, 0.1, 0.2, 0.4, 0.8, and 1.0 mg/kg/day for 30 days. Sheep receiving Ն0.2 mg/kg gained less weight than controls. After 16 days, animals receiving Ն0.4 mg/kg were depressed, reluctant to move, and did not eat their feed rations. All treatment groups had serum biochemical changes, including depressed ␣-mannosidase, increased aspartate aminotransferase and alkaline phosphatase, as well as sporadic changes in lactate dehydrogenase, sodium, chloride, magnesium, albumin, and osmolarity. Typical locoweed-induced cellular vacuolation was seen in the following tissues and swainsonine doses: exocrine pancreas at Ն0.05 mg/kg; proximal convoluted renal and thyroid follicular epithelium at Ն0.1 mg/kg; Purkinje's cells, Kupffer's cells, splenic and lymph node macrophages, and transitional epithelium of the urinary bladder at Ն0.2 mg/kg; neurons of the basal ganglia, mesencephalon, and metencephalon at Ն0.4 mg/kg; and cerebellar neurons and glia at Ն0.8 mg/kg. Histologic lesions were generally found when tissue swainsonine concentrations were ഡ150 ng/g. Both the clinical and histologic lesions, especially cerebellar lesions are suggestive of neurologic dysfunction even at low daily swainsonine doses of 0.2 mg/kg, suggesting that prolonged locoweed exposure, even at low doses, results in significant production losses as well as histologic and functional damage.
cerebrum, basal ganglia, hippocampus, thalamus, midbrain, and autonomic ganglia. 34, 35 Previous rodent studies suggested that locoweed poisoning progresses in a threshold-like fashion. Rats and hamsters dosed at less than 0.7 mg swainsonine/ kg bodyweight/day for 28 days were clinically normal and did not develop histologic lesions. Higher doses resulted in vacuolation of many different tissues, but those lesions did not become more severe. 28 These findings led to the hypothesis that locoweed toxicity is due to enzyme inhibition alone, resulting in a threshold-like dose response as susceptible cellular mannosidases are inhibited. Higher swainsonine doses do not incite additional cellular damage. Recent toxicokinetic studies have shown that tissues have different swainsonine concentrations. 27 Histologic lesions likely are related to tissue swainsonine concentrations.
Locoweeds are native plants that are uniquely adapted to the environments in which they are found. As a result, they are not easily controlled with chemicals or biologic agents. Other methods will have to be developed to minimize or avoid the effect of locoweed poisoning. Dose response information could be useful in developing such techniques. Animals could be managed so they do not ingest doses that result in significant production alterations or tissue damage. Currently, little information is available concerning the swain- sonine dose required to decrease production and cause biochemical changes or permanent neurologic damage in livestock. The objectives of this study were to determine swainsonine doses that result in clinical, biochemical, and histologic lesions and to determine if a correlation exists between swainsonine dose, tissue swainsonine concentrations, and locoweed-induced histologic lesions.
Materials and methods
Whole locoweed (Oxytropis sericea) plants were collected near Capulin, New Mexico. The plants were air-dried, ground to pass through a 2-mm screen, mixed, and randomly sampled. The combined samples were analyzed and found to contain 0.03% swainsonine by capillary gas chromatography. 17 Twenty-one mixed-breed wethers, weighing 41 Ϯ 3 kg, were dosed twice daily by gavage with ground locoweed and/or alfalfa to receive equal volumes and obtain swainsonine doses of 0.00, 0.05, 0.10, 0.20, 0.40, 0.80, and 1.00 mg swainsonine/kg body weight/day for 30 days. Beginning 14 days prior to dosing and during treatment, the animals were monitored for clinical signs of intoxication and weighed weekly, and blood and serum samples were collected weekly. At the end of treatment, all animals were humanely killed and necropsied. Brain, liver, thyroid, spleen, adrenal, and kidneys were weighed, and samples were collected for tissue swainsonine analysis and histologic evaluation. Histologic samples were prepared following previously described techniques including hematoxylin and eosin, periodic acid-Schiff, Bodian silver stain, and lectin histochemistry staining (lectins from Concanavalia ensiformis-ConA, Phytolacca americana-PWM, and Triticum vulgaris-WGA). 7, 28 Hematology analysis was performed with an impedance cell counter. a Serum biochemistries were measured with an automated chemistry analyzer following the manufacturer's recommendations. b Serum ␣-mannosidase and serum and tissue swainsonine concentrations were determined by previously described enzymatic assays. 26, 27 Standard curves for these assays were generated for serum and for each tissue for each assay. The standard swainsonine concentrations were verified by capillary gas chromatography. 17 The hematology and serum biochemistry results were compared with data for normal animals that were generated from the controls and pretreatment samples with a 95% confidence interval. The means for each treatment group were compared by analysis of variance (ANOVA) in a generalized linear model with times as the repeated measures. Mean body weights and tissue swainsonine concentrations were also compared by correlation analysis. Mean separations were determined by Duncan's multiple range test at P Ͻ 0.05 after a significant F-test at ␣ Ͻ 0.05 (Proc GLM and Cor, SAS Institute, Cary, NC).
Results
Sheep dosed with locoweed at Ն0.4 mg swainsonine/kg/day for 16 days had reduced feed consumption. After 20 days, the 0.8-and 1.0-mg/kg dose groups were depressed, and many animals trembled when stimulated. These animals also had dull-appearing eyes and were reluctant to stand and move. Locoweed-treated animals also had reduced weight gains; groups dosed at Ն0.2 mg swainsonine/kg/day had significantly lower weight gains over the 30-day study ( Table 1) . No difference was found in weight gains between the 0.2-, 0.4-, 0.8-, and 1.0-mg/kg groups. Interestingly, some of the animals dosed with relatively low amounts of swainsonine (0.05 and 0.1 mg/kg) had higher weight gains than controls (individual animal data not shown). However, when compared as groups, the 0.05 mg/kg animals grew significantly more than the 0.1mg/kg animals; however, neither group grew more than the control group (Table 1) .
After 30 days of locoweed dosing, animals in the high dose groups (Ն0.4 mg/kg) tended to have lower hematocrits than the other groups (P ϭ 0.06; Table 2 ). These animals also had lower mean erythrocyte volumes (28.5 Ϯ 0.3 fl, P ϭ 0.01) and erythrocyte hemoglobin concentrations (8.4 Ϯ 0.2, P ϭ 0.005), but all were within reported normal hematology ranges for sheep. Serum biochemical analyses showed several consistent changes, even in the low dose groups. Within 3 days of initiating dosing, all treated groups (0.05 mg/kg and higher) had significant decreases in serum ␣-mannosidase (P ϭ 0.001). The mean aspartate ami- * Swainsonine concentration were determined enzymatically with homogenates of one sagittal half of the organ. Lesions in some tissues were often confined to a single cell type, and the swainsonine concentrations in affected cells may have been much different than was seen in the homogenate. † n.d. ϭ not determined. notransferase (AST) activities were also increased above normal (P ϭ 0.01). Serum alkaline phosphatase (ALP) and lactate dehydrogenase (LDH) activities tended to be higher in treated groups (P ϭ 0.7 and 0.9, respectively, on day 3). Other alterations, including increased sodium (Na), decreased chloride (Cl), increased magnesium (Mg), increased albumin (Alb), and increased osmolarity (Osm), were sporadically observed in the high dose groups (Ն0.2 mg/kg; see Table  2 ). The electrolyte changes were mild and most were well within the ranges found in normal sheep. Swainsonine was detected in tissues analyzed from groups treated with locoweed. Liver, spleen, pancreas, and kidney had the highest swainsonine concentrations ( Table 1 ). Serum and tissue concentrations were directly correlated with the swainsonine dose (r ϭ 0.71). No significant differences between treatment groups were identified in any organ weights measured at necropsy.
The exocrine pancreas in all the locoweed treated animals, including the 0.05 mg/kg group, had increased numbers of apical vacuoles (Table 3 ; Fig. 1 ). The pancreatic vacuoles were slightly larger in the higher dose groups. Similar small vacuoles were also present in the proximal convoluted tubular epithelium of the kidney and follicular epithelial cells of the thyroid gland (Fig. 2) in the 0.1 mg/kg groups. All of these lesions were also seen in these tissues of the higher dose groups at about the same degree and distribution. At 0.2 mg/kg/day, vacuolation was seen in the spleen and lymph node monocyte/macrophage cells, urinary bladder epithelial cells, Kupffer's cells of the liver, and cerebellar Purkinje's cells ( Fig. 3) . At doses Ն0.4 mg/kg, lesions were present in the pulmonary macrophages, the adrenal cortex, and neurons of the gastrointestinal ganglia, basal ganglia, thalamus, hippocampus, corpora quadrigemina, and medulla oblongata. Doses of 0.8 and 1.0 mg/kg/day were required to produce lesions in neurons of the cerebral cortex, obex, spinal cord, glial cells, and myocardial interstitial cells. Animals of the 1.0-and 0.8-mg/kg groups also had shrunken and pyknotic neurons in the same nuclei that were vacuolated in the 0.1-and 0.2-mg/kg groups (Fig. 3) . The neuronal change in all groups was limited to neuron cell bodies and proximal axons; the white matter and myelin appeared unchanged. Although many of these tissues are heterogeneous and composed of many different cell types, histologic lesions were most often found when tissue swainsonine concentrations were approximately 150 ng/gm (Table  1) . Special lectin and silver stains supported the hematoxylin and eosin histologic findings and were especially useful in identifying subtle vacuolation. Locoweed-induced vacuolation in all tissue stained intensely with concanavalin A and pokeweed mitogen, as was previously reported. 28
Discussion
As in previous studies with sheep, cattle, and rodents, animals treated with Ն0.2 mg swainsonine/kg gained less weight than controls. 27, 28 Intoxicated animals often did not eat their full ration. Locoweed-associated production decreases have been attributed to neurologic anorexia, depression, and loss of neuromuscular ability to find, prehend, and masticate feed. 19, 22 Additionally, locoweed-induced alterations in glycoprotein, enzymes, and hormones are likely to reduce metabolic efficiency. 10, 18 Interestingly, several of the animals in the 0.05-mg/kg group gained more weight than did control animals. Similar short-lived growth enhancement has been anecdotally reported in animals as they began to ingest locoweed during both range and pen studies at our laboratory. Nutritionally, locoweed is comparable with alfalfa and is reported to be more nutritious than many neighboring forbs and grasses. 20 Nutritional difference may explain some of the observed initial growth enhancement seen in the field, but these wethers were fed nutrient-balanced diets. Possibly low swainsonine doses, given for short durations, may actually enhance animal production. Short-term swainsonine treatment has enhanced production and secretion of certain hormones and cytokines in in vitro studies. 6, 11 Additional work is needed to determine the effects of swainsonine on specific growth hormones and to verify if this trend of temporary growth enhancement is real and under what conditions it may be useful in managing livestock grazing on locoweed-infested pastures.
Although the swainsonine-dosed wethers used in this study often had hematology changes suggestive of a microcytic-hypochromic anemia, these changes were sporadic and not significantly different than in control animals. This contrasts sharply with other studies in cattle where a pronounced anemia was noted. 29 Because recent studies have demonstrated that altered mannosidase II activity results in dyserythropoiesis, more information is needed to determine the effect of dose and duration of swainsonine intoxication on erythrocyte kinetics and metabolism. 8 Even the lowest swainsonine doses resulted in significant inhibition of serum ␣-mannosidase and in-creased AST activities within the first 3 days of the study (data from day 15 shown in Table 2 ). These changes occurred before swainsonine was detected in the serum. The enzyme-inhibition swainsonine assay has a detection limit of about 20 ng/ml in the serum, and previous studies have shown that the serum swainsonine half-life in sheep is about 20 hours. 25, 27 Because the sheep were sampled in the morning before dosing, the serum swainsonine concentrations in these sheep were likely at their lowest concentration and often undetectable. Although the ␣-mannosidase and AST activities were altered in 0.05-and 0.10-mg/kg groups, these animals had no observable clinical change. These groups gained weight similar to or better than control animals, and they developed minimal histologic change (mild vacuolation of the exocrine pancreas, thyroid follicular epithelium, and renal proximal tubular epithelium). No additional inhibition of ␣-mannosidase or increase in AST activity was found in animals that received higher locoweed doses, suggesting that, though sensitive to small swainsonine doses and locoweed poisoning, serum ␣-mannosidase and AST activities are poor indicators of the extent or duration of intoxication. The other biochemical changes (ALP, LDL, electrolytes, and Alb) were minimal and sporadic. Most of these parameters were also within normal ranges for animals at this laboratory. Additional work is needed to develop techniques to better identify locoweed poisoning and better prognose the outcome of poisoned animals.
Normal exocrine pancreas epithelia contain secretory vacuoles that are apically positioned. The 0.05mg/kg dose group appeared to have increased numbers of these apical vacuoles (Fig. 1) . Cytoplasmic vacuolation was also seen in the epithelium of the renal proximal tubules and the thyroid in the 0.1-mg/kg group (Fig. 2) . These changes were subtle, whereas more consistent and discrete vacuolation, including cerebellar neuronal vacuolation, was seen only in animals dosed at Ն0.2 mg/kg. Higher doses of 0.7 mg swainsonine/kg/day for 28 days produced similar pancreatic, renal, and thyroid histologic lesions in rodents. 28 Much higher doses, Ͼ7 mg/kg, were required to produce neurologic lesions in rats. This finding suggests that sheep are either much more sensitive to the effects of swainsonine or that significant interspecies differences exist in swainsonine toxicokinetics. Pharmacokinetic data suggest swainsonine is distributed at much lower levels in rodent tissues and that rodents excrete swainsonine very rapidly. 3 Interestingly, histologic lesions in most tissues seem to be related to the swainsonine concentration. For example, the kidneys had mean swainsonine concentrations of 154 ng/g when histologic lesions were first observed. Splenic lesions were seen when spleen swainsonine concentration was 280 ng/g. Liver lesions were seen when livers had a mean swainsonine concentration of 319 ng/g. Brain tissue did not follow this trend: certain neuron populations developed lesions when brain swainsonine concentrations were quite low (36 ng/g); however, diffuse vacuolation in most neurons and glia was seen only when brain swainsonine concentrations were Ն154 ng/g. Histologic change is likely a reflection of tissue swainsonine concentrations. Tissues that accumulate relatively high swainsonine concentrations develop histologic changes before other tissues with lower swainsonine concentrations. Alternatively, lesion development could be due to differences in the metabolic activity of the tissue or inhibition differences in tissue-specific mannosidases. Swainsonine has been shown to have various affinities for different mannosidases, and interspecies differences are likely. 30 As in previous studies, 28, 36 once lesions developed in tissues, increases in the extent, distribution, or character of the vacuolation were minimal with increased swainsonine dose. This minimal increase is suggestive of a threshold-like response. Similar patterns also were seen clinically and biochemically; no significant dif- ferences were found in weight gains, ␣-mannosidase activity, AST, or ALP between the groups dosed at swainsonine doses Ն0.2 mg/kg/day. This similarity could be useful in developing management schemes to minimize the effect of locoweed poisoning in livestock.
Monocyte and macrophage-like cells appear to be very sensitive to locoweed-induced changes. Vacuolation of macrophages in the spleen and lymph nodes is among the first lesions to be identified, 34 and in this study, they were present in groups of wethers dosed with relatively small amounts of locoweed. Vacuolation of lymphocytes and macrophages also was identified in cattle receiving relatively low swainsonine doses of 0.25 mg/kg/day. 29 Locoweed poisoning has been associated with various immunologic alterations, especially lymphocyte function. 2, 4, 5, 14, 35, 37 Recent work suggests that macrophage activation, phagocytosis and endocytosis, lysosome metabolism and antigen processing are easily altered by swainsonine intoxication. 9, 15, 24, 31 Because macrophages are altered within several days at low swainsonine doses, additional work is needed to better identify the effects of locoweed poisoning on macrophage function and immunocompetence.
These findings suggest that swainsonine doses of 0.2 mg/kg/day or higher for 30 days result in a significant decrease in weight gains, as well as biochemical and histologic lesions. For grazing animals, these changes equated to ingestion of locoweed at about 3-10% of an animal's diet. Most studies suggest that after animals begin eating locoweed, locoweed generally composes about 30% of their diets. 23, 26 Under most field conditions, regulation of locoweed consumption, especially to some low exposure level, would be difficult. 21, 23 Because higher swainsonine doses resulted in no detectable increase in the severity of clinical or histologic changes, a better approach may be to manage animals so they ingest high swainsonine doses over short time periods. These periods would be followed by periods of detoxification. Studies are currently under way to determine the effects of such intermittent locoweed intoxication.
